Home > Financial Ratios > BAFNA PHARMACEUTICALS

BAFNA PHARMACEUTICALS
Core EBITDA Growth

    Back to All Ratios
BAFNA PHARMACEUTICALS is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for BAFNA PHARMACEUTICALS
Please provide your vote to see the results

BAFNA PHARMACEUTICALS Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Core EBITDA Growth(%) 48.74-4.88-22.9339.0023.66

What is the latest Core EBITDA Growth ratio of BAFNA PHARMACEUTICALS ?

The latest Core EBITDA Growth ratio of BAFNA PHARMACEUTICALS is 48.74 based on Mar2026 Standalone results.
Year Core EBITDA Growth
Mar202648.74
Mar2025-4.88
Mar2024-22.93
Mar202339.00
Mar202223.66

How is Core EBITDA Growth of BAFNA PHARMACEUTICALS Trending?

Years Core EBITDA Growth % Change
Mar2026 48.74
Positive
Mar2025 -4.88
Negative
Mar2024 -22.93
Negative
Mar2023 39
64.84
Mar2022 23.66 -

Other Financial Ratios of BAFNA PHARMACEUTICALS


Compare Core EBITDA Growth ratio of peers of BAFNA PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS ₹717.0 Cr 11.6% 10.8% 258% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹463,791.0 Cr 1.7% -1.4% 21.7% Stock Analytics
DIVIS LABORATORIES ₹245,081.0 Cr 2% 10.3% 49.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹190,351.0 Cr -0.4% -0.5% 38.6% Stock Analytics
CIPLA ₹112,212.0 Cr -0.5% -2.5% -10.2% Stock Analytics
DR REDDYS LABORATORIES ₹96,906.3 Cr -1.2% 0% -7.1% Stock Analytics


BAFNA PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS

11.6%

10.8%

258%

SENSEX

-1%

-2.9%

-4.9%


You may also like the below Video Courses